Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2001-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPHEART.2001.281.3.H1122PMID 11514278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of lipids on the functional and metabolic recovery from global myocardial stunning in isolated rabbit hearts.

  2000cited by this paper
• Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure.

  2000cited by this paper
• The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

  2000influential reference
• Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome.

  2000cited by this paper
• Citrate release by perfused rat hearts: a window on mitochondrial cataplerosis.

  2000cited by this paper
• Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study.

  2000cited by this paper
• Nitric oxide and endothelin-1 in coronary and pulmonary circulation.

  1999cited by this paper
• Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice.

  1999cited by this paper
• Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alpha-adrenergic-dependent contractions of rabbit resistance arteries.

  1999cited by this paper
• Fatty acid oxidation in the reperfused ischemic heart.

  1999cited by this paper
• NO and cardiac diastolic function.

  1999cited by this paper
• The pH-Partition Profile of the Anti-Ischemic Drug Trimetazidine May Explain Its Reduction of Intracellular Acidosis

  1999cited by this paper
• Nitric oxide and coronary endothelial dysfunction in humans.

  1999cited by this paper
• Cardiac accumulation of citrate during brief myocardial ischaemia and reperfusion in the pig in vivo.

  1998cited by this paper
• Role of endothelin-A receptors in ischemic contracture and reperfusion injury.

  1998cited by this paper
• High‐energy phosphates metabolism and recovery in reperfused ischaemic hearts

  1998cited by this paper
• Effects of Trimetazidine on Metabolic and Functional Recovery of Postischemic Rat Hearts

  1998cited by this paper
• The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig.

  1998cited by this paper
• Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.

  1997cited by this paper
• Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart.

  1997cited by this paper
• Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondrial

  1997cited by this paper
• Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart.

  1997cited by this paper
• Hypertriglyceridemia and Hyperinsulinemia Are Potent Inducers of Endothelin-1 Release in Humans

  1996cited by this paper
• Myocardial contractile response to nitric oxide and cGMP.

  1996cited by this paper
• Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia.

  1995cited by this paper
• Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring.

  1995cited by this paper
• Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo.

  1995cited by this paper
• Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite.

  1995cited by this paper
• Trimetazidine: in vitro influence on heart mitochondrial function.

  1995cited by this paper
• Regulation of bioenergetics in O2-limited isolated rat hearts.

  1994cited by this paper
• Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias.

  1994cited by this paper
• Effects of Trimetazidine on Ischemic Contracture in Isolated Perfused Rat Hearts

  1994cited by this paper
• Endothelin and myocardial ischemia

  1994cited by this paper
• NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action.

  1994cited by this paper
• The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion.

  1993cited by this paper
• Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells.

  1993cited by this paper
• Relation between glycolysis and calcium homeostasis in postischemic myocardium.

  1992cited by this paper
• Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts.

  1992cited by this paper
• Trimetazidine inhibits Na+,K(+)-ATPase activity, and overdrive hyperpolarization in guinea-pig ventricular muscles.

  1991cited by this paper
• Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions.

  1991cited by this paper
• Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

  1991cited by this paper
• Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.

  1991cited by this paper
• EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries.

  1991cited by this paper
• Trimetazidine inhibits Na+,K(+)-ATPase activity, and overdrive hyperpolarization in guinea-pig ventricular muscles.

  1991cited by this paper
• Influence of glucose and insulin on the exaggerated diastolic and systolic dysfunction of hypertrophied rat hearts during hypoxia.

  1990cited by this paper
• Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts.

  1990cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

  1984cited by this paper
• Atherogenesis: a postprandial phenomenon.

  1979cited by this paper
• Effects of Substrates on Tissue Metabolic Changes in the Isolated Rat Heart during Underperfusion and on Release of Lactate Dehydrogenase and Arrhythmias during Reperfusion

  1978cited by this paper
• Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

  1974cited by this paper

• Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury

  2023cites this paper
• Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial

  2023cites this paper
• HIV Infection and Cocaine Use Induce Endothelial Damage and Dysfunction In Africa Americans

  2020cites this paper
• Clinical benefits of targeting cardiac cells directly with trimetazidine in patients with coronary disease and diabetes

  2017cites this paper
• Lipid Emulsion Rapidly Restores Contractility in Stunned Mouse Cardiomyocytes: A Comparison With Therapeutic Hypothermia

  2014cites this paper
• Trimetazidine and Cellular Response in Cardiopulmonary Bypass

  2013cites this paper
• Is hypertriglyceridemia a key detrimental factor or associative triggering factor for cardiovascular abnormalities?

  2012cites this paper
• HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans.

  2012cites this paper
• AICAR and Trimetazidine in University of Wisconsin Solution are Effective to Increase Survival in Recipients Transplanted with Steatotic Livers

  2012cites this paper
• Metabolic Modulation: A New Therapeutic Target in Treatment of Heart Failure

  2011cites this paper
• Fatty liver and ischemia/reperfusion: are there drugs able to mitigate injury?

  2011cites this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cites this paper
• Treatment of unstable angina with trimetazidine

  2009cites this paper
• Effects of metabolic approach in diabetic patients with coronary artery disease.

  2009cites this paper
• Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction.

  2008cites this paper
• Optimizing cardiac energy substrate metabolism: a novel therapeutic intervention for ischemic heart disease

  2008cites this paper
• Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.

  2008cites this paper
• Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine.

  2008cites this paper
• Addition of adenosine monophosphate‐activated protein kinase activators to University of Wisconsin solution: A way of protecting rat steatotic livers

  2007cites this paper
• Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts.

  2007cites this paper
• The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.

  2007cites this paper
• Partial inhibition of fatty acid β-oxidation with trimetazidine - a novel approach to the treatment of ischemic heart disease

  2007cites this paper
• Effect of selective 3-ketoacyl coenzyme A thiolase inhibition on glucose metabolism in cardiac patients

  2006cites this paper
• A PATHOLOGIC ROLE FOR ANGIOTENSIN II AND ENDOTHELIN-1 IN CARDIAC REMODELLING AND ISCHAEMIA AND REPERFUSION INJURY IN A RAT MODEL OF THE METABOLIC SYNDROME.

  2006cites this paper
• Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.

  2006cites this paper
• Lipotoxicity in cardiac and skeletal muscle

  2006cites this paper
• Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients.

  2004cites this paper
• Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

  2003cites this paper
• Chronic and Intermittent Hypoxia Induce Different Degrees of Myocardial Tolerance to Hypoxia-Induced Dysfunction

  2002cites this paper
• Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.

  2002cites this paper